Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes

[1]  David J. Galas,et al.  sRNAnalyzer—a flexible and customizable small RNA sequencing data analysis pipeline , 2017, Nucleic acids research.

[2]  Inyoul Y. Lee,et al.  The Importance of Standardization on Analyzing Circulating RNA , 2017, Molecular Diagnosis & Therapy.

[3]  Z.Q. Mao,et al.  Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypass , 2017, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[4]  Yanfang Zou,et al.  Urinary MicroRNA-30c-5p and MicroRNA-192-5p as potential biomarkers of ischemia–reperfusion-induced kidney injury , 2017, Experimental biology and medicine.

[5]  K. Iwasaki,et al.  MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation , 2017, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[6]  Dongshan Zhang,et al.  p53 activates miR-192-5p to mediate vancomycin induced AKI , 2016, Scientific Reports.

[7]  R. Townsend,et al.  MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  D. Allan,et al.  Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury. , 2016, Kidney international.

[9]  H. Tilg,et al.  Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes , 2016, Diabetes.

[10]  Dan-ping Wang,et al.  The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy , 2016, Scientific Reports.

[11]  Yue Cao,et al.  A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis , 2016, Scientific Reports.

[12]  M. Bugliani,et al.  MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells , 2016, Diabetes.

[13]  A. Weisz,et al.  The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. , 2016, Cell reports.

[14]  F. Borràs,et al.  Size-Exclusion Chromatography-based isolation minimally alters Extracellular Vesicles’ characteristics compared to precipitating agents , 2016, Scientific Reports.

[15]  Vikas Ghai,et al.  Recent progress toward the use of circulating microRNAs as clinical biomarkers , 2016, Archives of Toxicology.

[16]  Shaohua Fan,et al.  Epigenetic modification of miR-10a regulates renal damage by targeting CREB1 in type 2 diabetes mellitus. , 2016, Toxicology and applied pharmacology.

[17]  A. Józkowicz,et al.  TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation , 2016, Mediators of inflammation.

[18]  C. Mathews,et al.  Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study , 2016, Scientific Reports.

[19]  Ben He,et al.  Circulating MicroRNA‐188, ‐30a, and ‐30e as Early Biomarkers for Contrast‐Induced Acute Kidney Injury , 2016, Journal of the American Heart Association.

[20]  F. Rodríguez‐Artalejo,et al.  Glycosylated haemoglobin as a predictor of cardiovascular events and mortality: a protocol for a systematic review and meta-analysis , 2016, BMJ Open.

[21]  Zheng Zhang,et al.  Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy , 2016, Journal of diabetes research.

[22]  A. Laucevičius,et al.  Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review , 2016, Cardiovascular research.

[23]  Klaus Jung,et al.  Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma , 2016, PloS one.

[24]  Chun-jun Li,et al.  Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis. , 2016, American journal of translational research.

[25]  N. Pottier,et al.  miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy , 2016, Scientific Reports.

[26]  F. Liu,et al.  Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis , 2016, International journal of molecular sciences.

[27]  Wan-Chun Li,et al.  Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan , 2016, International journal of medical sciences.

[28]  K. Ramalingam,et al.  Role of microRNA 21 in diabetes and associated/related diseases. , 2016, Gene.

[29]  M. Li,et al.  MicroRNA 152 regulates hepatic glycogenesis by targeting PTEN , 2016, The FEBS journal.

[30]  M. Kumari,et al.  Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats , 2016, PloS one.

[31]  D. Karolina,et al.  MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction , 2016, International journal of molecular sciences.

[32]  T. Guo,et al.  Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy. , 2016, Journal of diabetes and its complications.

[33]  Y. Ba,et al.  The microRNA-124-iGluR2/3 pathway regulates glucagon release from alpha cells , 2016, Oncotarget.

[34]  G. Cai,et al.  Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy , 2016, Scientific Reports.

[35]  Qingjuan Liu,et al.  miR-148a-3p overexpression contributes to glomerular cell proliferation by targeting PTEN in lupus nephritis. , 2016, American journal of physiology. Cell physiology.

[36]  M. Rudnicki,et al.  Renal microRNA‐ and RNA‐profiles in progressive chronic kidney disease , 2016, European journal of clinical investigation.

[37]  Pingsheng Liu,et al.  Inhibition of miR-200c Restores Endothelial Function in Diabetic Mice Through Suppression of COX-2 , 2016, Diabetes.

[38]  Y. Wang,et al.  Plasma extracellular RNA profiles in healthy and cancer patients , 2016, Scientific Reports.

[39]  Hong Li,et al.  Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis , 2016, Scientific Reports.

[40]  N. Hamburg,et al.  MicroRNA-181b Improves Glucose Homeostasis and Insulin Sensitivity by Regulating Endothelial Function in White Adipose Tissue. , 2016, Circulation research.

[41]  Z. Giricz,et al.  Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods , 2015, PloS one.

[42]  Antonio Luigi Pastore,et al.  Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma , 2015, International journal of molecular sciences.

[43]  R. Komers,et al.  miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. , 2015, Clinical science.

[44]  T. Lei,et al.  Rs12976445 Polymorphism is Associated with Risk of Diabetic Nephropathy Through Modulating Expression of MicroRNA-125 and Interleukin-6R , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[45]  Hongbing Shen,et al.  Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN , 2015, Scientific Reports.

[46]  Steven A. Bailey,et al.  Identification of Promising Urinary MicroRNA Biomarkers in Two Rat Models of Glomerular Injury. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[47]  R. Ain,et al.  MicroRNA-141-3p and miR-200a-3p regulate insulin-like growth factor 2 during mouse placental development , 2015, Molecular and Cellular Endocrinology.

[48]  E. Flowers,et al.  Circulating micrornas associated with glycemic impairment and progression in Asian Indians , 2015, Biomarker Research.

[49]  Baocheng Wang,et al.  miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression , 2015, Journal of experimental & clinical cancer research : CR.

[50]  L. Hympanova,et al.  Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction , 2015, PloS one.

[51]  N. Robles,et al.  Non-Proteinuric Diabetic Nephropathy , 2015, Journal of clinical medicine.

[52]  A. Gutiérrez-Escolano,et al.  Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human , 2015, Renal failure.

[53]  Ling Zhou,et al.  A MicroRNA Signature in Gestational Diabetes Mellitus Associated with Risk of Macrosomia , 2015, Cellular Physiology and Biochemistry.

[54]  Vijay P. Singh,et al.  Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7 , 2015, Diabetes.

[55]  D. Galas,et al.  Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes , 2015, Journal of clinical medicine.

[56]  X. Liu,et al.  Serum MicroRNA-99a Helps Detect Acute Rejection in Renal Transplantation. , 2015, Transplantation proceedings.

[57]  Alan B Leichtman,et al.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  B. Ponte,et al.  A Pilot Study Identifying a Set of microRNAs As Precise Diagnostic Biomarkers of Acute Kidney Injury , 2015, PloS one.

[59]  K. Nakao,et al.  MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy , 2015, Diabetologia.

[60]  R. Jove,et al.  MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids. , 2015, The Journal of clinical investigation.

[61]  V. Mohan,et al.  Circulating MiRNAs of ‘Asian Indian Phenotype’ Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes , 2015, PloS one.

[62]  Lei Yang,et al.  MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway , 2015, International Journal of Obesity.

[63]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[64]  Ryan T Fuchs,et al.  Bias in Ligation-Based Small RNA Sequencing Library Construction Is Determined by Adaptor and RNA Structure , 2015, PloS one.

[65]  Yan Bao,et al.  Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways. , 2015, International journal of clinical and experimental pathology.

[66]  Y. Kokubo,et al.  Hemoglobin A1c Levels and the Risk of Cardiovascular Disease in People Without Known Diabetes , 2015, Medicine.

[67]  W. Xie,et al.  Cross-talks between microRNAs and mRNAs in pancreatic tissues of streptozotocin-induced type 1 diabetic mice. , 2015, Biomedical reports.

[68]  A. Krolewski,et al.  Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes , 2015, Diabetes.

[69]  G. Yousef,et al.  miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1 , 2015, Oncotarget.

[70]  M. Chan,et al.  MicroRNA-10b downregulation mediates acute rejection of renal allografts by derepressing BCL2L11. , 2015, Experimental cell research.

[71]  J. D. de Fijter,et al.  Circulating MicroRNAs Associate With Diabetic Nephropathy and Systemic Microvascular Damage and Normalize After Simultaneous Pancreas–Kidney Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[72]  M-L Si,et al.  MicroRNA-185 Targets SOCS3 to Inhibit Beta-Cell Dysfunction in Diabetes , 2015, PloS one.

[73]  Sha Li,et al.  Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function , 2015, Genom. Proteom. Bioinform..

[74]  Gareth W. Price,et al.  Mind the gap: connexins and cell–cell communication in the diabetic kidney , 2015, Diabetologia.

[75]  X. Chen,et al.  A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma , 2015, Scientific Reports.

[76]  M. Matsumoto,et al.  Decreased miR-26a Expression Correlates with the Progression of Podocyte Injury in Autoimmune Glomerulonephritis , 2014, PloS one.

[77]  Mark E Molitch,et al.  Diabetic Kidney Disease: A Report From an ADA Consensus Conference , 2014, Diabetes Care.

[78]  K. Zen,et al.  Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[79]  Zhiyong Yang,et al.  MicroRNA‐27b Targets Gremlin 1 to Modulate Fibrotic Responses in Pulmonary Cells , 2014, Journal of cellular biochemistry.

[80]  L. Musante,et al.  Use and Isolation of Urinary Exosomes as Biomarkers for Diabetic Nephropathy , 2014, Front. Endocrinol..

[81]  Lesley Cheng,et al.  Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. , 2014, Kidney International.

[82]  M. T. Grande,et al.  Effect of Angiotensin II and Small GTPase Ras Signaling Pathway Inhibition on Early Renal Changes in a Murine Model of Obstructive Nephropathy , 2014, BioMed research international.

[83]  Rounak Nassirpour,et al.  Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms , 2014, BMC Genomics.

[84]  D. Fischer,et al.  Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. , 2014, The Journal of clinical endocrinology and metabolism.

[85]  K. Homma,et al.  miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction , 2014, Scientific Reports.

[86]  M. Karsdal,et al.  The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? , 2014, Fibrogenesis & tissue repair.

[87]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[88]  Jun Zhao,et al.  MiR‐142‐3p represses TGF‐β‐induced growth inhibition through repression of TGFβR1 in non‐small cell lung cancer , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  Longxin Qiu,et al.  Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice. , 2014, Free radical biology & medicine.

[90]  J. Sundquist,et al.  Determination of 14 Circulating microRNAs in Swedes and Iraqis with and without Diabetes Mellitus Type 2 , 2014, PloS one.

[91]  Sophie Rome,et al.  Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin Sensitization , 2014, Diabetes Care.

[92]  Gloria Alvarez-Llamas,et al.  Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. , 2014, Journal of proteomics.

[93]  P. Katzmarzyk,et al.  HbA1c and Coronary Heart Disease Risk Among Diabetic Patients , 2014, Diabetes Care.

[94]  F. Sánchez‐Madrid,et al.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.

[95]  E. Donadi,et al.  Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients , 2013, BMC Research Notes.

[96]  Ming Li,et al.  Acarbose Reduces Blood Glucose by Activating miR-10a-5p and miR-664 in Diabetic Rats , 2013, PloS one.

[97]  D. Cimino,et al.  Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy , 2013, PloS one.

[98]  Ming Wang,et al.  MiR-181b targets Six2 and inhibits the proliferation of metanephric mesenchymal cells in vitro. , 2013, Biochemical and biophysical research communications.

[99]  Antony Rodriguez,et al.  MicroRNA-22 Is a Master Regulator of Bone Morphogenetic Protein-7/6 Homeostasis in the Kidney* , 2013, The Journal of Biological Chemistry.

[100]  M. Martínez-Larrad,et al.  Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers , 2013, PloS one.

[101]  H. Cathro,et al.  The urine microRNA profile may help monitor post-transplant renal graft function , 2013, Kidney international.

[102]  C. Reilly,et al.  MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro , 2013, Autoimmunity.

[103]  R. Regazzi,et al.  Circulating microRNAs as novel biomarkers for diabetes mellitus , 2013, Nature Reviews Endocrinology.

[104]  D. Galas,et al.  Correction: Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes , 2013, PLoS ONE.

[105]  Xiyun Ye,et al.  Both ERK/MAPK and TGF-Beta/Smad Signaling Pathways Play a Role in the Kidney Fibrosis of Diabetic Mice Accelerated by Blood Glucose Fluctuation , 2013, Journal of diabetes research.

[106]  B. Jiang,et al.  Insulin Promotes Glucose Consumption via Regulation of miR-99a/mTOR/PKM2 Pathway , 2013, PloS one.

[107]  V. Gattone,et al.  Decreased MicroRNA Is Involved in the Vascular Remodeling Abnormalities in Chronic Kidney Disease (CKD) , 2013, PloS one.

[108]  F. Dotta,et al.  MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications , 2013 .

[109]  F. Magni,et al.  Urinary exosomes and diabetic nephropathy: a proteomic approach. , 2013, Molecular bioSystems.

[110]  E. Brennan,et al.  Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1. , 2013, Journal of the American Society of Nephrology : JASN.

[111]  B. Mayer,et al.  miRNA Profiling Discriminates Types of Rejection and Injury in Human Renal Allografts , 2013, Transplantation.

[112]  N. Pottier,et al.  Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis , 2013, PloS one.

[113]  Zhijie Jiang,et al.  MicroRNA Expression in Alpha and Beta Cells of Human Pancreatic Islets , 2013, PloS one.

[114]  Kyle J. Gaulton,et al.  The miRNA Profile of Human Pancreatic Islets and Beta-Cells and Relationship to Type 2 Diabetes Pathogenesis , 2013, PloS one.

[115]  D. Galas,et al.  Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes , 2013, PloS one.

[116]  K. Zen,et al.  Urinary MicroRNA-10a and MicroRNA-30d Serve as Novel, Sensitive and Specific Biomarkers for Kidney Injury , 2012, PloS one.

[117]  D. Constam,et al.  Bicc1 links the regulation of cAMP signaling in polycystic kidneys to microRNA-induced gene silencing. , 2012, Journal of molecular cell biology.

[118]  R. Dahiya,et al.  Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer , 2012, PloS one.

[119]  J. Halimi,et al.  The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. , 2012, Diabetes & metabolism.

[120]  P. Hougaard,et al.  Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression , 2012, Experimental diabetes research.

[121]  M. Chopp,et al.  Exosome‐Mediated Transfer of miR‐133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite Outgrowth , 2012, Stem cells.

[122]  Ramkumar Veppathur Mohan,et al.  MicroRNA-30d Induces Insulin Transcription Factor MafA and Insulin Production by Targeting Mitogen-activated Protein 4 Kinase 4 (MAP4K4) in Pancreatic β-Cells* , 2012, The Journal of Biological Chemistry.

[123]  Jelle J. Goeman,et al.  Genome-Wide MicroRNA Expression Analysis of Clear Cell Renal Cell Carcinoma by Next Generation Deep Sequencing , 2012, PloS one.

[124]  F. Schena,et al.  Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[125]  J. Lozano,et al.  Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. , 2012, Journal of the American Society of Nephrology : JASN.

[126]  Lin Sun,et al.  Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and Myofibroblasts , 2012, PloS one.

[127]  T. H. Lam,et al.  Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[128]  Aaron N. Chang,et al.  MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways , 2012, Science Translational Medicine.

[129]  D. Warburton,et al.  MIR-99a and MIR-99b Modulate TGF-β Induced Epithelial to Mesenchymal Plasticity in Normal Murine Mammary Gland Cells , 2012, PloS one.

[130]  Jie Fan,et al.  Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. , 2012, Biochemical and biophysical research communications.

[131]  Martin S. Taylor,et al.  Evolution of the human-specific microRNA miR-941 , 2012, Nature Communications.

[132]  An Xie,et al.  Upregulation of MicroRNA-210 Regulates Renal Angiogenesis Mediated by Activation of VEGF Signaling Pathway under Ischemia/Perfusion Injury in vivo and in vitro , 2011, Kidney and Blood Pressure Research.

[133]  Youhua Liu.  Cellular and molecular mechanisms of renal fibrosis , 2011, Nature Reviews Nephrology.

[134]  E. Abraham,et al.  Identification of a microRNA signature in renal fibrosis: role of miR-21. , 2011, American journal of physiology. Renal physiology.

[135]  F. Su,et al.  Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.

[136]  Mitsuo Kato,et al.  A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. , 2011, Kidney international.

[137]  Cheuk-Man Yu,et al.  TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. , 2011, Journal of the American Society of Nephrology : JASN.

[138]  Arunmozhiarasi Armugam,et al.  MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus , 2011, PloS one.

[139]  Xueyuan Bai,et al.  miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. , 2011, Journal of the American Society of Nephrology : JASN.

[140]  Danish Sayed,et al.  MicroRNAs in development and disease. , 2011, Physiological reviews.

[141]  K. Ma,et al.  Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy , 2011, PloS one.

[142]  Jing Zhou,et al.  Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease , 2011, BMC Systems Biology.

[143]  K. Suszták,et al.  Tracing the footsteps of glomerular insulin signaling in diabetic kidney disease. , 2011, Kidney international.

[144]  Yong Huang,et al.  Biological functions of microRNAs: a review , 2011, Journal of Physiology and Biochemistry.

[145]  J. Long,et al.  MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy* , 2011, The Journal of Biological Chemistry.

[146]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[147]  P. Nilsson,et al.  New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR) , 2010, Journal of internal medicine.

[148]  G. Camussi,et al.  Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.

[149]  Merlin C. Thomas,et al.  miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression , 2010, Diabetes.

[150]  M. Mayr,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.

[151]  Johan Skog,et al.  Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. , 2010, Kidney International.

[152]  Z. Dong,et al.  Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. , 2010, Journal of the American Society of Nephrology : JASN.

[153]  W. Lieberthal,et al.  The role of the mammalian target of rapamycin (mTOR) in renal disease. , 2009, Journal of the American Society of Nephrology : JASN.

[154]  G. Hirokawa,et al.  Plasma miR-208 as a biomarker of myocardial injury. , 2009, Clinical chemistry.

[155]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[156]  M. Kretzler,et al.  Urine podocyte mRNAs mark progression of renal disease. , 2009, Journal of the American Society of Nephrology : JASN.

[157]  Darshana Dadhania,et al.  MicroRNA expression profiles predictive of human renal allograft status , 2009, Proceedings of the National Academy of Sciences.

[158]  Xiaoqing Tang,et al.  Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. , 2009, RNA.

[159]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[160]  Benedikt Brors,et al.  Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease , 2008, BMC Genomics.

[161]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[162]  Asl Yu,et al.  Tight junction composition is altered in the epithelium of polycystic kidneys , 2008, The Journal of pathology.

[163]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[164]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[165]  S. Kaneko,et al.  The renin–angiotensin system contributes to renal fibrosis through regulation of fibrocytes , 2008, Journal of hypertension.

[166]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[167]  R. Regazzi,et al.  Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs , 2008, Biological chemistry.

[168]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[169]  N. Iwai,et al.  MicroRNA and 3T3-L1 pre-adipocyte differentiation. , 2006, RNA.

[170]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[171]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[172]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[173]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[174]  D. Cohen,et al.  MAPK signaling and the kidney. , 2000, American journal of physiology. Renal physiology.

[175]  H. Geuze,et al.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.

[176]  R. Holl,et al.  Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. , 1999, Diabetes care.

[177]  Y. Dodurga,et al.  MicroRNA-125b as a new potential biomarker on diagnosis of renal ischemia-reperfusion injury. , 2017, The Journal of surgical research.

[178]  H. Bergmeister,et al.  miR-182-5p Inhibition Ameliorates Ischemic Acute Kidney Injury. , 2017, The American journal of pathology.

[179]  S. Dremier,et al.  Paving the Route to Plasma miR-208a-3p as an Acute Cardiac Injury Biomarker: Preclinical Rat Data Supports Its Use in Drug Safety Assessment. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[180]  H. Axelson,et al.  The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma , 2015 .

[181]  R. Meuwissen,et al.  The role of microRNAs in biological processes. , 2014, Methods in molecular biology.

[182]  E. Bocchi,et al.  The emerging role of miR-208a in the heart. , 2013, DNA and cell biology.

[183]  N. Iwai,et al.  MicroRNA and 3 T 3L 1 pre-adipocyte differentiation , 2006 .